Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial

التفاصيل البيبلوغرافية
العنوان:	Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
المؤلفون:	Keech, Cheryl, Miller, Vicki E, Rizzardi, Barbara, Hoyle, Christopher, Pryor, Melinda J, Ferrand, Jonathan, Solovay, Ken, Thalen, Marcel, Noviello, Stephanie ^*, Goldstein, Peter, Gorringe, Andrew, Cavell, Breeze, He, Qiushui, Barkoff, Alex-Mikael, Rubin, Keith, Locht, Camille
المصدر:	In The Lancet 11-17 March 2023 401(10379):843-855
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!